121. Reversibility of alexithymia with effective treatment of moderate‐to‐severe psoriasis: longitudinal data from EPIDEPSO. (1st February 2019) Authors: Sampogna, F.; Puig, L.; Spuls, P.; Girolomoni, G.; Radtke, M.A.; Kirby, B.; Brunori, M.; Bergmans, P.; Smirnov, P.; Rundle, J.; Castiglia, A.; Lavie, F.; Paul, C. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
122. Reversibility of alexithymia with effective treatment of moderate‐to‐severe psoriasis: longitudinal data from EPIDEPSO. (26th November 2018) Authors: Sampogna, F.; Puig, L.; Spuls, P.; Girolomoni, G.; Radtke, M.A.; Kirby, B.; Brunori, M.; Bergmans, P.; Smirnov, P.; Rundle, J.; Castiglia, A.; Lavie, F.; Paul, C. Journal: British journal of dermatology Issue: Volume 180:Number 2(2019) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
123. Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey. (1st July 2021) Authors: Mahil, S.K.; Yates, M.; Langan, S.M.; Yiu, Z.Z.N.; Tsakok, T.; Dand, N.; Mason, K.J.; McAteer, H.; Meynell, F.; Coker, B.; Vincent, A.; Urmston, D.; Vesty, A.; Kelly, J.; Lancelot, C.; Moorhead, L.; Bachelez, H.; Bruce, I.N.; Capon, F.; Contreras, C.R. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
124. Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey. (9th March 2021) Authors: Mahil, S.K.; Yates, M.; Langan, S.M.; Yiu, Z.Z.N.; Tsakok, T.; Dand, N.; Mason, K.J.; McAteer, H.; Meynell, F.; Coker, B.; Vincent, A.; Urmston, D.; Vesty, A.; Kelly, J.; Lancelot, C.; Moorhead, L.; Bachelez, H.; Bruce, I.N.; Capon, F.; Contreras, C.R. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
125. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting. (28th February 2013) Authors: Navarro, R.; Vilarrasa, E.; Herranz, P.; Puig, L.; Bordas, X.; Carrascosa, J.M.; Taberner, R.; Ferrán, M.; García‐Bustinduy, M.; Romero‐Maté, A.; Pedragosa, R.; García‐Diez, A.; Daudén, E. Journal: British journal of dermatology Issue: Volume 168:Number 3(2013:Mar.) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
126. Safety in moderate‐to‐severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti‐tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trials. (15th May 2020) Authors: Puig, L.; Tsai, T.‐F.; Bhutani, T.; Uy, J.; Ramachandran, P.; Song, M.; You, Y.; Gooderham, M.; Lebwohl, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 8(2020) Page Start: 1744 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
127. Saprochaete capitata disseminated infection presenting as macular rash after haematopoietic stem cell transplantation. (8th June 2020) Authors: Garcia‐Melendo, C.; Cubiró, X.; López‐Sánchez, C.; Turienzo, M.; Mozos, A.; Puig, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 11(2020) Page Start: e748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
128. SAT0018 Identification of new epistatic interactions with the HLA region in the genetic etiology of psoriasis and psoriatic arthritis. (23rd January 2014) Authors: Marsal, S.; Hernanz, J.M.; Cañete, J.D.; Fonseca, E.; Ferrandiz, C.; Unamuno, P.; Puig, L.; Fernández-Sueiro, J.L.; Sanmartí, R.; Rodriguez, J.; Gratacόs, J.; Dauden, E.; Sánchez-Carazo, J.L.; Lόpez-Estebaranz, J.L.; Moreno-Ramirez, D.; Queirό, R.; Montilla, C.; Torre-Alonso, J.C.; Pérez-Venegas,... Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
129. SAT0267 Safety of Ustekinumab from the Placebo-Controlled Periods of Psoriatic Arthritis and Psoriasis Clinical Developmental Programs. (23rd January 2014) Authors: McInnes, I.; Papp, K.; Puig, L.; Reich, K.; Ritchlin, C.; Strober, B.; Rahman, P.; Kavanaugh, A.; Mendelsohn, A.; Song, M.; Chan, D.; Shen, Y. K.; Li, S.; Gottlieb, A. B. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
130. SAT0271 Continued Improvement of Signs and Symptoms in Ustekinumab-Treated Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study. (23rd January 2014) Authors: Kavanaugh, A.; McInnes, I. B.; Gottlieb, A. B.; Puig, L.; Rahman, P.; Ritchlin, C.; Li, S.; Wang, Y.; Doyle, M.; Mendelsohn, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗